Described is a pharmaceutical preparation for treating blood coagulation disorders comprising an effective amount of vWF propeptide as well as a method for producing such a preparation.

 
Web www.patentalert.com

< Inhibitors of cytosolic phospholipase A.sub.2

> 1-[(4-Ethynylphenyl)]-2-[(phenyl)]-pyrrolidine-1,2-dicarboxamide derivatives as inhibitors of coagulation factors Xa and VIIa for the treatment of thrombosis

> Methods for diagnosing, imaging and treating atherosclerotic disease
~ 00532